Found: 11
Select item for more details and to access through your institution.
Graft-versus-leukemia Effect of HLA-haploidentical Central-memory T-cells Expanded With Leukemic APCs and Modified With a Suicide Gene.
- Published in:
- Molecular Therapy, 2013, v. 21, n. 2, p. 466, doi. 10.1038/mt.2012.227
- By:
- Publication type:
- Article
Extracellular NGFR Spacers Allow Efficient Tracking and Enrichment of Fully Functional CAR-T Cells Co-Expressing a Suicide Gene.
- Published in:
- Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.00507
- By:
- Publication type:
- Article
Myeloid cell-based delivery of IFN-γ reprograms the leukemia microenvironment and induces anti-tumoral immune responses.
- Published in:
- EMBO Molecular Medicine, 2021, v. 13, n. 10, p. 1, doi. 10.15252/emmm.202013598
- By:
- Publication type:
- Article
Efficacy of CAR-T immunotherapy in MET overexpressing tumors not eligible for anti-MET targeted therapy.
- Published in:
- Journal of Experimental & Clinical Cancer Research (17569966), 2022, v. 41, n. 1, p. 1, doi. 10.1186/s13046-022-02479-y
- By:
- Publication type:
- Article
Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT.
- Published in:
- Nature Communications, 2019, v. 10, n. 1, p. N.PAG, doi. 10.1038/s41467-019-08871-1
- By:
- Publication type:
- Article
Case report: Ponatinib as a bridge to CAR-T cells and subsequent maintenance in a patient with relapsed/refractory Philadelphia-like acute lymphoblastic leukemia.
- Published in:
- Frontiers in Oncology, 2023, v. 12, p. 1, doi. 10.3389/fonc.2022.1100105
- By:
- Publication type:
- Article
Human T cells engineered with a leukemia lipid-specific TCR enables donor-unrestricted recognition of CD1c-expressing leukemia.
- Published in:
- Nature Communications, 2021, v. 12, n. 1, p. 1, doi. 10.1038/s41467-021-25223-0
- By:
- Publication type:
- Article
Full chimaeric CAR.CIK from patients engrafted after allogeneic haematopoietic cell transplant: Feasibility, anti‐leukaemic potential and alloreactivity across major human leukocyte antigen barriers.
- Published in:
- British Journal of Haematology, 2023, v. 200, n. 1, p. 64, doi. 10.1111/bjh.18469
- By:
- Publication type:
- Article
Overcoming the toxicity hurdles of genetically targeted T cells.
- Published in:
- Cancer Immunology, Immunotherapy, 2015, v. 64, n. 1, p. 123, doi. 10.1007/s00262-014-1641-9
- By:
- Publication type:
- Article
Adoptive immunotherapy with genetically modified lymphocytes in allogeneic stem cell transplantation.
- Published in:
- Immunological Reviews, 2014, v. 257, n. 1, p. 165, doi. 10.1111/imr.12130
- By:
- Publication type:
- Article
Next-Generation Manufacturing Protocols Enriching T<sub>SCM</sub> CAR T Cells Can Overcome Disease-Specific T Cell Defects in Cancer Patients.
- Published in:
- Frontiers in Immunology, 2020, v. 11, p. 1, doi. 10.3389/fimmu.2020.01217
- By:
- Publication type:
- Article